How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case study
Brief alcohol intervention—where to from here? Challenges remain for research and practice
BRIEF ALCOHOL INTERVENTION: TIME FOR TRANSLATIONAL RESEARCH
UNEXPLORED TERRITORIES
MEETING THE CHALLENGES FOR RESEARCH AND PRACTICE FOR BRIEF ALCOHOL INTERVENTION
BRIEF ALCOHOL INTERVENTION RESEARCH AND PRACTICE—TOWARDS A BROADER PERSPECTIVE
University of Michigan Addiction Research Center (UMARC): development, evolution, and direction
‘To prove this is the industry's best hope’: big tobacco's support of research on the genetics of nicotine addiction
Seeing America—diary of a drug-focused study tour made in 1967
Health outcomes associated with methamphetamine use among young people: a systematic review
Commentary on Marshall et al. (2010): Are long-term negative health consequences of methamphetamine use important to youth?
Modeling missing binary outcome data in a successful web-based smokeless tobacco cessation program
Commentary on Smolkowski et al. (2010): Why is it important to assume that non-responders in tobacco cessation trials have relapsed?
Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006
Commentary on Rey et al. (2010): How to improve estimates on alcohol-attributable burden?
Effects of a community intervention to reduce the serving of alcohol to intoxicated patrons
Rumination as a predictor of drinking behaviour in alcohol abusers: a prospective study
Ambient temperature and risk of death from accidental drug overdose in New York City, 1990–2006
Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia
Flashblood: blood sharing among female injecting drug users in Tanzania
The epidemiology of cannabis use and cannabis-related harm in Australia 1993–2007
Impairment due to cannabis and ethanol: clinical signs and additive effects
If you try to stop smoking, should we pay for it? The cost–utility of reimbursing smoking cessation support in the Netherlands
Commentary on Vemer et al. (2010): When is smoking cessation really cost-effective?
Risk perception and smoking behavior in medically ill smokers: a prospective study
Predicting the life-time benefit of school-based smoking prevention programmes
Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey
Mephentermine dependence without psychosis: a Brazilian case report
News and Notes